LABU241129C105000
- 21.50
- +6.50+43.33%
Direxion Daily S&P Biotech Bull 3x Shares ETF Newsroom
Wednesday Ends With Index Decline | Wall Street Today
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
How Is The Market Feeling About United Therapeutics?
Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
Gilead Acquires Investigational HIV Vaccine From Spanish Biotech Aelix
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Looking Into Vertex Pharmaceuticals's Recent Short Interest
S&P 500, Dow Hit Records Right After Open | Live Stock
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Price Over Earnings Overview: Gilead Sciences
Analyst Expectations For Sarepta Therapeutics's Future